JW (Cayman) Therapeutics Co. Ltd
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-0.4629 | 46.22 | -101% | -0.6742 | -31.34% |
| P/S |
|
0.4235 | 4.38 | -90.34% |
|
|
| P/BV |
|
0.4184 | 5.41 | -92.26% |
|
|
| P/FCF |
|
-5.71 | 26.95 | -121.21% |
|
|
| Ev/Ebitda |
|
-0.0432 | 17.44 | -100.25% |
|
|
| Ev/S |
|
0.1338 | 4.5 | -97.03% |
|
|
| Ev/FCF |
|
-0.4419 | 39.19 | -101.13% |
|
|
| E/P |
|
-2.16 | 1.06 | -303.36% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-309.65 | 23.21 | -1434.05% | -757.49 | -59.12% |
| ROE |
|
-297.29 | 14.54 | -2144.77% |
|
|
| ROA |
|
-221.84 | 7.4 | -3098.86% |
|
|
| ROIC |
|
0 | 14.06 | -100% |
|
|
| ROS |
|
-373.68 | 11.1 | -3466.16% |
|
|
| ROCE |
|
-362.12 | 17.57 | -2161.58% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1184 | 2.91 | -104.07% | -0.2517 | -52.96% |
| Nеt Debt/Ebitda |
|
0.0939 | 0.0376 | 149.88% |
|
|
| Debt/Ratio |
|
0.2517 | 0.2175 | 15.73% |
|
|
| Debt/Equity |
|
0.4381 | 1.1 | -60.27% |
|
|
| Debt/Net Income |
|
-0.0981 | 9 | -101.09% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.7 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.85 | -100% | ||
| DSI |
|
0 | 0.7795 | -100% |
|
|
| Average dividend growth |
|
0 | -359.57 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 3.31 | -100% |
|
|
| Average percentage for payments |
|
0 | 151.74 | -100% |
|
|
| Difference from average difference in sector |
|
-1.7 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
20509.16 | 356.39 | 5654.7% | ||
| Growth impulse Ebitda in 5 years |
|
118.38 | 337.43 | -64.92% | ||
| Growth impulse Net Income in 5 years |
|
154.24 | 247.92 | -37.79% | ||
| Growth impulse FCF in 5 years |
|
-14.07 | 229.5 | -106.13% | ||
| Growth impulse EPS in 5 years |
|
569.64 | 436.02 | 30.65% |
IP Score
4.83/10
